Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.75.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
BQ.1.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.524NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.524NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.15.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.15.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.59 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.59 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBRNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBRNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DJ.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DJ.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.10.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FF.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.626NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.626NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.629NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.629NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19749.2South Korea
GA.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EP.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EP.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CL.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CL.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBF.8.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAUNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAUNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.17 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.25.1.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.25.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.409NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.409NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.83NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used